ARTL

Artelo Biosciences, Inc. Common Stock

1.21

USD

ARTL Earnings Reports

Positive Surprise Ratio

ARTL beat 7 of 15 last estimates.

47%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

-$1.60

Implied change from Q3 25 (Revenue/ EPS)

-59.70%

Implied change from Q4 24 (Revenue/ EPS)

-77.21%

Artelo Biosciences, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, ARTL reported earnings of -3.97 USD per share (EPS) for Q3 25, missing the estimate of -0.83 USD, resulting in a -374.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -8.16% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.60 USD, with revenue projected to reach -- USD, implying an decrease of -59.70% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

enGene Holdings Inc. Common Stock

Report Date

Dec 22, 2025 For Q4 25

Estimate

-$0.57

Actual

-$0.73

Surprise

-25.95%

Outlook Therapeutics, Inc. Common Stock

Report Date

Dec 19, 2025 For Q4 25

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.47%

Citius Oncology, Inc. Common Stock

Report Date

Dec 23, 2025 For Q4 25

Estimate

-$0.12

Actual

-$0.06

Surprise

+50.98%

FAQ

What were Artelo Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Artelo Biosciences, Inc. Common Stock reported EPS of -$3.97, missing estimates by -374.65%, and revenue of $0.00, 0% as expectations.

How did the market react to Artelo Biosciences, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -8.16%, changed from $1.96 before the earnings release to $1.80 the day after.

When is Artelo Biosciences, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Artelo Biosciences, Inc. Common Stock's next earnings report?

Based on 3 analysts, Artelo Biosciences, Inc. Common Stock is expected to report EPS of -$1.60 and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.